so you placed your balls out of bounce eh ?
[it must have hurt -g]
TEVA almost hitting ALL TIME HIGHS....
Teva Pharmaceutical Industries Limited to Join the NASDAQ-100 Index Beginning November 7, 200
PR NEWSWIRE - October 31, 2002 18:30
NEW YORK, Oct 31, 2002 /PRNewswire via COMTEX/ -- Teva Pharmaceutical Industries Limited's American Depositary Receipt (Nasdaq: TEVA) will become a component of the NASDAQ-100 Index(R) (Nasdaq: NDX), effective at the beginning of trading Thursday, November 7, 2002. Teva will also be included in the NASDAQ-100 Index Tracking Stock(SM) (Amex: QQQ). Teva Pharmaceutical Industries Limited will replace Concord EFS, Inc.
Teva Pharmaceutical Industries Limited, headquartered in Israel, develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients.
The NASDAQ-100 Index, launched in January 1985, is one of the most widely followed benchmarks in the world. The NASDAQ-100 Index Tracking Stock represents ownership in the NASDAQ-100 Trust. The Trust holds a portfolio of equity securities that compose the NASDAQ-100 Index and aims to provide investment results that generally correspond with its performance.
NASDAQ (OTC Bulletin Board: NDAQ) is the world's largest electronic stock market. With approximately 3,800 companies, NASDAQ lists more companies and trades more shares per day than any other U.S. market. Over the past five years, NASDAQ has outpaced all other U.S. markets in listing IPOs. It is home to category-defining companies that are leaders across all areas of business including technology, retail, communications, financial services, media and biotechnology industries. NASDAQ is a key driver of capital formation. For more information about NASDAQ, visit the NASDAQ Web site at nasdaq.com or the NASDAQ Newsroom(SM) at nasdaqnews.com .
The Trustee for the Nasdaq-100 Trust is required to adjust the composition of the Trust within 3 business days of the effective date of a change to the composition of the Nasdaq-100 Index.
Investment returns and principal value will fluctuate so that an investor's shares, when redeemed or sold, may be worth more or less than the original cost.
For more complete information about Nasdaq-100 Index Tracking Stock(SM), including trust performance charges, expenses and potential risks, obtain a prospectus from your broker, or call 800-843-2639 or visit the web site at nasdaq-100.com . Read it carefully before you invest.
While there is no assurance that the performance of the Nasdaq-100 Index can be fully matched, the Nasdaq-100 Index Tracking Stock is designed to provide, before expenses, investment results that generally correspond to the performance of the Nasdaq-100 Index. Index performance does not reflect the fees and costs associated with investing. Investors cannot invest directly in the Index.
The sponsor of the Nasdaq-100 Trust(SM), a unit investment trust, is Nasdaq Financial Products Services, Inc. ("NFPS"), a wholly owned subsidiary of The Nasdaq Stock Market, Inc. ("Nasdaq," and collectively with its affiliates except NFPS, the "Corporations").
"Nasdaq" and related marks are trademarks or service marks of Nasdaq and have been licensed for use for certain purposes by NFPS. The Nasdaq-100 Index is composed and calculated by Nasdaq without regard to Nasdaq-100 Shares. The Corporations make no warranty, express or implied, and bear no liability with respect to Nasdaq-100 Shares. The Corporations and NFPS make no warranty, express or implied, and bear no liability with respect to the Nasdaq-100 Index, its use or any data included therein.
ALPS Distributors, Inc., a registered broker-dealer, is distributor for the Trust.
Make Your Opinion Count - Click Here tbutton.prnewswire.com
SOURCE The NASDAQ Stock Market
CONTACT: Media Contact: Wayne Lee, +1-301-978-4875, or Issuer Contact: Lisa Chaney, +1-301-978-8281, both of The NASDAQ Stock Market; or Dorit Meltzer of Teva Pharmaceutical Industries Limited, +1-011-972-3-926-7554
URL: nasdaqnews.com |
